Advancing European healthcare in Strasbourg
News
9 Oct 2025
Healthcare

From Tuesday, 7 to Wednesday, 8 October, AmCham EU travelled to the European Parliament in Strasbourg, France to engage with MEPs on the future of EU health policy. In meetings with over a dozen policymakers, members underscored the importance of a competitive, innovation-driven life sciences sector that ensures timely patient access to medicines and technologies. The discussions also covered the General Pharmaceutical Legislation, the Medical Devices Regulation, the Critical Medicines Act and the upcoming Biotech Act. The delegation called for evidence-based, proportionate policies that promote regulatory coherence and support Europe’s global leadership in health innovation. 

Related items

News
27 Oct 2025

Advancing EU health policy through competitiveness and innovation

On Monday, 27 October, AmCham EU met with Lorena Boix-Alonso, Deputy Director-General, Directorate-General for Health and Food Safety, European Commission, for an exchange on the role of health policy in strengthening the EU’s competitiveness. The discussion focused on how to foster innovation while ensuring patient safety, as well as ways to streamline the legislative framework to improve efficiency and uphold high standards of care. AmCham EU highlighted the importance of evidence-based, future-proof regulation that supports a resilient health system and drives innovation. Continued dialogue is essential to advancing shared goals for Europe’s health agenda. 

Healthcare
Read more
Read more about Advancing EU health policy through competitiveness and innovation
How the Critical Medicines Act will strengthen Europe’s life sciences sector
News
4 May 2025

How the Critical Medicines Act will strengthen Europe’s life sciences sector

On Wednesday, 30 April, Thibaut L'Ortye, Senior Director of Public Affairs, AmCham EU, joined a panel discussion on the Critical Medicines Act (CMA). Hosted by the European Policy Centre, Mr L'Ortye underlined the need for open and resilient supply chains to ensure continued access to medicines. He also highlighted the CMA’s potential to strengthen Europe's competitiveness and improve patient access. Avoiding protectionist measures and aligning the CMA with the EU’s wider simplification efforts is essential to attract investment into the Single Market. The discussion highlighted the importance of public-private collaboration to build a more competitive life sciences sector in the EU. 

Healthcare
Read more
Read more about How the Critical Medicines Act will strengthen Europe’s life sciences sector
How will the EU life science strategy achieve competitiveness?
News
24 Mar 2025

How will the EU life science strategy achieve competitiveness?

On Tuesday, 25 March, AmCham EU hosted a discussion on the EU’s forthcoming life sciences strategy and its role in enhancing the sector’s global competitiveness. Ann-Sofie Rönnlund, Member of Cabinet to Commissioner Zaharieva, outlined the Commission’s vision to promote innovation, resilience and patient access. Moderated by Felix Uedelhoven (GE Healthcare), Chair, Healthcare Committee, AmCham EU, the event explored how the EU can create a supportive regulatory and investment environment. Speakers stressed the importance of public-private collaboration and adequate public funding to boost research and innovation, positioning Europe as a global leader in health and ensuring long-term sustainability for patients, healthcare systems and businesses. 

Healthcare
Read more
Read more about How will the EU life science strategy achieve competitiveness?